COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Pre-exposure and Post-exposure new prophylactic treatments against COVID-19 in healthcare workers
- Dietary behaviors, food accessibility, and handling practices during SARS-CoV-2 pandemic in Benin
- The role of nutrition in strengthening immune system against newly emerging viral diseases: case of SARS-CoV-2
- New insight on nutrition and COVID-19 pandemic
- Nutritional status of school-age children and adolescents in eastern and southern Africa: A scoping review
- Nutrition in contemporary Zimbabwe: a situational analysis
- Calcium status in Moroccan children and adolescents assessed by 24-hour urinary excretion
- Micronutrient supplementation among pregnant women in western Algeria
- Prevalence of anemia, hematocrit variations, and micronutrient supplementation practices among pregnant women attending antenatal clinics in Ibadan, Southwest Nigeria
- Assessment of vitamin A levels in breast milk and serum of lactating mothers in Southeast Nigeria
You may also start an advanced similarity search for this article.

NAJFNR is licensed under